Mode
Text Size
Log in / Sign up
N/A N=65 Diagnostic

MMG vs. EMG for Cortical Breach Detection

Low Back Disorder

Enrolled (actual)
65
Serious AEs
4.9%
Results posted
Aug 2025
Primary outcome: Primary: Success of Pedicle Screw Trajectories — 296; 5; 2 Screws

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Triggered Electromyography (Device); Mechanomyography (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Francis Farhadi
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Success of Pedicle Screw Trajectories
296; 5; 2
SECONDARY
Change From Baseline in the Numeric Rating Scale (NRS) Questionnaire for Pain.
-3.80; -4.15
SECONDARY
Change From Baseline in the Oswestry Disability Index Version 2.1A
-47.4
SECONDARY
Change From Baseline in the PROMIS Global-10
26.6; 14.6
SECONDARY
Change in the Short-From (SF-36) Health Survey
SECONDARY
Hospital Readmission at 30 Days
3.28
SECONDARY
Hospital Readmission at 90 Days
1.64

Summary

The purpose of this study is to determine how well mechanomyography (MMG) and electromyography (EMG) prevent cortical bone breaches, or the pinching of a nerve from screw placement, in patients having lower back surgery requiring hardware. Both MMG and EMG are devices approved by the FDA to detect the location of nerves during surgery so they can be avoided. The results from both tests will be compared to one another to determine if one is better at accurately locating nerves than the other.

Eligibility Criteria

Inclusion Criteria

  • scheduled to undergo a one-, two-, or three-level posterolateral spinal fusion surgery using Depuy Synthes Expedium pedicle screw instrumentation.
  • over the age of 18 years old
  • unresponsive to conservative care for a minimum of 6 months
  • psychosocially, mentally, and physically able to fully consent and comply with this protocol

Exclusion Criteria

  • preexisting medical condition or comorbidity that makes them a poor candidate
  • open wound local to the operative area, or rapid joint disease, bone absorption, or osteoporosis
  • requires medications that may interfere with bone or soft tissue healing
  • active local or systemic infection
  • metal sensitivity/foreign body sensitivity
  • implanted pacemaker
  • morbidly obese, defined as a body mass index (BMI) greater than 45
  • osteoporosis
  • involved in or planning to engage in litigation or receiving Workers Compensation related to neck or back pain.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05352048). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search